Getting a Crohn’s Diagnosis: Why It Takes So Long and What to Expect

Getting a Crohn’s Diagnosis: Why It Takes So Long and What to Expect

Many people with Crohn’s disease experience symptoms for months or even years before receiving a formal diagnosis. The delay can be frustrating and isolating, particularly when symptoms disrupt daily life. Understanding why diagnosis takes time and what the process involves can help set realistic expectations and reduce anxiety during an uncertain period.

What is Crohn’s disease?

Crohn’s disease is a type of inflammatory bowel disease (IBD) that causes chronic inflammation in the gastrointestinal tract. Unlike ulcerative colitis, which affects only the colon and rectum, Crohn’s can occur anywhere from the mouth to the anus, though it most commonly affects the terminal ileum and the beginning of the colon. The inflammation is typically patchy, with healthy tissue between inflamed sections, and can extend through multiple layers of the bowel wall. This complexity contributes to the diagnostic challenge.

Why diagnosis takes time

Symptoms overlap with common conditions

The early symptoms of Crohn’s disease, including abdominal pain, diarrhoea, fatigue, and weight loss, are non-specific. They can easily be attributed to irritable bowel syndrome, food intolerances, infections, or stress-related digestive problems. Because these conditions are far more common than Crohn’s, healthcare professionals often explore and rule out other causes first. This stepwise approach is medically appropriate but extends the timeline.

Symptoms fluctuate

Crohn’s disease often follows a relapsing and remitting pattern, with periods of active symptoms followed by intervals of relative calm. During a consultation, a patient may feel better than they did weeks earlier, making the severity less apparent. Blood tests and stool samples taken during a quieter phase may also appear less concerning, further delaying specialist referral.

No single diagnostic test exists

There is no single test that definitively confirms Crohn’s disease. Diagnosis relies on a combination of clinical history, blood tests, stool tests, imaging, and endoscopy with biopsy. Each investigation provides a piece of the puzzle, but none alone is sufficient. Inflammation markers such as C-reactive protein (CRP) and faecal calprotectin can support the diagnosis, but they are not specific to Crohn’s and can be elevated in other conditions.

Access to specialist services varies

In many healthcare systems, patients need a referral from a general practitioner to see a gastroenterologist. Waiting times for specialist appointments, endoscopy, and imaging vary widely depending on location and demand. Even when symptoms are concerning, the pathway involves multiple stages, each with its own waiting period.

What to expect during the diagnostic process

Initial assessment

Your general practitioner will take a detailed history of your symptoms, including their frequency, duration, and severity. They will ask about bowel habits, any blood or mucus in your stool, weight loss, family history of IBD, and other relevant medical history. A physical examination may include checking for abdominal tenderness and signs of anaemia or malnutrition.

Blood tests

Blood tests are typically among the first investigations. These may include a full blood count to check for anaemia or raised white blood cells, CRP to assess inflammation, liver and kidney function, and tests for nutritional deficiencies such as vitamin B12, folate, and iron. Elevated inflammatory markers support the need for further investigation but are not diagnostic on their own.

Stool tests

Stool samples may be tested for infections, including bacteria, viruses, and parasites, to rule out infectious causes. Faecal calprotectin, a protein released by white blood cells in the gut, is often measured. Elevated levels suggest intestinal inflammation and can help differentiate IBD from IBS, though they do not distinguish between Crohn’s disease and ulcerative colitis.

Imaging

Imaging studies help visualise the bowel structure and identify inflammation, strictures, fistulas, or abscesses. Common options include magnetic resonance enterography (MRE), which provides detailed images of the small bowel, and computed tomography (CT) scans for urgent situations. Ultrasound is sometimes used to assess bowel wall thickness. These non-invasive tests provide valuable information about areas difficult to reach with endoscopy.

Endoscopy and biopsy

Endoscopy allows direct visualisation of the gut lining and is a key component of diagnosis. A colonoscopy examines the colon and terminal ileum, while an upper endoscopy assesses the oesophagus, stomach, and duodenum if symptoms suggest involvement in those areas. During the procedure, tissue samples (biopsies) are taken from both inflamed and normal-looking areas. These samples are examined microscopically to identify features consistent with Crohn’s disease, such as granulomas, chronic inflammation, and architectural changes.

Capsule endoscopy

If Crohn’s disease is suspected in the small bowel but standard endoscopy has not provided a diagnosis, capsule endoscopy may be used. This involves swallowing a small camera that takes thousands of images as it passes through the digestive tract. It is particularly useful for detecting inflammation in otherwise difficult-to-access areas.

What happens after diagnosis

Once Crohn’s disease is confirmed, your gastroenterologist will discuss the extent and severity of the disease, and recommend a tailored treatment plan. Treatment aims to reduce inflammation, manage symptoms, and prevent complications. It is important to understand that Crohn’s is a chronic condition requiring ongoing monitoring and adjustment of therapy.

Practical takeaways

  • Keep a symptom diary, noting the frequency and severity of pain, bowel movements, blood, weight changes, and any patterns you notice.
  • Be open and specific about your symptoms, even if they feel embarrassing. Details matter.
  • Ask your general practitioner about the timeline for referrals and tests, and whether there are steps you can take while waiting.
  • Bring a list of questions to appointments, and consider taking notes or having someone accompany you.
  • Continue to attend scheduled appointments and tests, even if symptoms improve temporarily.
  • Remember that diagnosis is a process, and the time taken reflects the need for thoroughness rather than a lack of concern.

Conclusion

The path to a Crohn’s disease diagnosis is rarely straightforward. The overlapping symptoms, fluctuating nature of the condition, and need for multiple investigations all contribute to delays. While this can be frustrating, the stepwise approach ensures that the diagnosis is accurate and that other conditions are appropriately excluded. Understanding the process and knowing what to expect can help reduce uncertainty and support effective communication with healthcare professionals during this time.

References

  1. Gomollón F, Dignass A, Annese V, et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: Part 1: Diagnosis and medical management. J Crohns Colitis. 2017;11(1):3-25. doi:10.1093/ecco-jcc/jjw168
  2. Sturm A, Maaser C, Mendall M, et al. European Crohn’s and Colitis Organisation topical review on IBD and the environment. J Crohns Colitis. 2019;13(8):927-936. doi:10.1093/ecco-jcc/jjz051
  3. Mowat C, Cole A, Windsor A, et al. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2011;60(5):571-607. doi:10.1136/gut.2010.224154
  4. Baumgart DC, Sandborn WJ. Crohn’s disease. Lancet. 2012;380(9853):1590-1605. doi:10.1016/S0140-6736(12)60026-9
  5. Gralnek IM, Defranchis R, Seidman E, et al. Development of a capsule endoscopy scoring index for small bowel mucosal inflammatory change. Aliment Pharmacol Ther. 2008;27(2):146-154. doi:10.1111/j.1365-2036.2007.03556.x
  6. Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L. Crohn’s disease. Lancet. 2017;389(10080):1741-1755. doi:10.1016/S0140-6736(16)31711-1

This article is intended for informational and educational purposes only. It does not constitute medical advice and should not be used as a substitute for professional medical guidance, diagnosis, or treatment.

About the Author

Team Vance

Team Vance is the editorial team at Vance Medical, the medical foods company behind this hub. Vance Medical has spent more than thirty years in gastrointestinal medicine, developing nutritional products under the same regulatory frameworks that govern prescription medicines. The Hub exists to make that ground accessible, to people living with Crohn's disease, ulcerative colitis, IBS and related conditions, and to the clinicians treating them. Articles are written and edited in-house, and clinical claims are referenced to published research, with each study linked to its DOI so you can read the source rather than take our word for it. We publish primarily for a UK audience. Nothing here replaces advice from your own GP, gastroenterologist or dietitian.

For general information only. This article is for general information and is not a substitute for professional medical advice, diagnosis or treatment. It reflects the best available evidence at the time of writing and may not capture the most recent developments. Always talk to your GP, pharmacist or healthcare team before acting on anything you read here, and never disregard professional advice or delay seeking it because of something on this site. Where we mention products from Vance Medical Foods Ltd we identify this clearly.
Last updated 1 September 2026
×
×